Circulating KRAS variant-specific shedding and association with survival in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) receiving chemoimmunotherapy-MedSci.cn

Circulating KRAS variant-specific shedding and association with survival in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) receiving chemoimmunotherapy

Till, JE; McDaniel, L; Pfeiffer, SM; Maurer, DM; Yu, J; Spencer, C; Lyman, JP; Cabanski, CR; Da Silva, DM; Abbott, C; Boyle, SM; Rahma, OE; Fisher, GA; Ko, AH; Wainberg, ZA; Wolff, RA; O'Reilly, EM; O'Hara, MH; Vonderheide, RH; Carpenter, EL

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):

科室
- - 订阅+
  - 更多科室
工具
服务